⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28318997 | 0.97 | — | — | |
| SCHEMBL284309 | 0.97 | — | — | |
| SCHEMBL28143225 | 0.97 | KDM4E (0.48) | — | |
| SCHEMBL12501791 | 0.95 | KDM4E (0.46) | — | |
| SCHEMBL10657468 | 0.95 | — | — | |
| Water SCHEMBL27495950 | 0.95 | — | — | |
| SCHEMBL1685016 | 0.95 | — | — | |
| SCHEMBL9812780 | 0.95 | — | — | |
| Phosphine SCHEMBL28140868 | 0.95 | — | — | |
| Formaldehyde SCHEMBL28212738 | 0.93 | KDM4E (0.45) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11213530-B2 | Gallium in the treatment of coronavirus disease | BERNSTEIN LAWRENCE RICHARD (US) | 2022-01-04 | — | — | US | claimed |
| WO-2021258086-A2 | GALLIUM IN THE TREATENT OF CORONAVIRUS DISEASE | BERNSTEIN LAWRENCE (US) | 2021-12-23 | — | — | WO | claimed |
| US-20210275544-A1 | Gallium in the treatment of coronavirus disease | BERNSTEIN LAWRENCE RICHARD (US) | 2021-09-09 | — | — | US | claimed |
| US-20060222628-A1 | Gallium complexes of 3-hydroxy-4-pyrones to treat infection by intracellular prokaryotes and DNA viruses | BERNSTEIN LAWRENCE R | 2006-10-05 | — | — | US | claimed |
| US-20030083308-A1 | Gallium complexes of 3-hydroxy-4-pyrones to treat infection by intracellular prokaryotes and DNA viruses | BERNSTEIN LAWRENCE R (US) | 2003-05-01 | — | — | US | claimed |
| US-20020160055-A1 | Methods for treating human immunodeficiency virus infections with gallium compositions | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2002-10-31 | — | — | US | claimed |
| US-6087354-A | ORALLY ADMINISTERING TO PROVIDE GALLIUM TO HUMANS AND OTHER MAMMALS FOR A WIDE VARIETY OF MEDICAL AND VETERINARY APPLICATIONS; TREATMENT OF CANCERS, HYPERCALCEMIA, CERTAIN DISORDERS OF CALCIUM HOMEOSTASIS AND CERTAIN BONE DISEASES | BERNSTEIN LAWRENCE RICHARD (US) | 2000-07-11 | — | — | US | claimed |
| US-6004951-A | MOUTHS; BIOAVAILABILITY; TREATING, PREVENTING AND DIAGNOSING CANCER AND BONE DISORDERS | BERNSTEIN LAWRENCE RICHARD (US) | 1999-12-21 | — | — | US | claimed |
| US-5998397-A | Gallium complexes of 3-Hydroxy-4-pyrones to treat or prevent bone disease | BERNSTEIN LAWRENCE RICHARD (US) | 1999-12-07 | — | — | US | claimed |
| US-5981518-A | ADMINISTERING HYDROXYPYRONE GALLIUM COMPLEX FOR TREATING AND PROPHYLAXIS OF BLOOD-METAL CONCENTRATIONS, OSTEOPOROSIS, CANCERS, PAGET'S DISEASE IN MAMMALS AND ANIMALS | BERNSTEIN LAWRENCE RICHARD (US) | 1999-11-09 | — | — | US | claimed |
| US-5968922-A | ADMINISTERING NEUTRAL 3:1 (HYDROXYPYRONE:GALLIUM) COMPLEX | BERNSTEIN LAWRENCE RICHARD (US) | 1999-10-19 | — | — | US | claimed |
| WO-2021258086-A2 | GALLIUM IN THE TREATENT OF CORONAVIRUS DISEASE | BERNSTEIN LAWRENCE (US) | 2021-12-23 | — | — | WO | disclosed |
| US-9616133-B2 | Orally administrable gallium compositions and methods of use | BERNSTEIN LAWRENCE R (US) | 2017-04-11 | — | — | US | disclosed |
| US-20170096434-A1 | DERIVATIZED CORROLES AND METALLOCORROLES AND THEIR USE AS IMAGING AND THERAPEUTIC AGENTS | CALIFORNIA INSTITUTE OF TECHNOLOGY | 2017-04-06 | — | — | US | disclosed |
| US-9492551-B2 | Orally administrable gallium compositions and methods of use | BERNSTEIN LAWRENCE R (US) | 2016-11-15 | — | — | US | disclosed |
| EP-0612246-A4 | PHARMACEUTICAL COMPOSITIONS OF GALLIUM COMPLEXES OF 3-HYDROXY-4-PYRONES. | BERNSTEIN LAWRENCE RICHARD (US) | 1995-04-19 | — | — | EP | disclosed |
| EP-0612246-A1 | PHARMACEUTICAL COMPOSITIONS OF GALLIUM COMPLEXES OF 3-HYDROXY-4-PYRONES | BERNSTEIN, Lawrence Richard (US) | 1994-08-31 | — | — | EP | disclosed |
| US-5258376-A | Treatment of hypercalcemia, tumors, bone diseases | BERNSTEIN LAWRENCE R (US) | 1993-11-02 | — | — | US | disclosed |
| WO-1993009776-A1 | PHARMACEUTICAL COMPOSITIONS OF GALLIUM COMPLEXES OF 3-HYDROXY-4-PYRONES | BERNSTEIN LAWRENCE RICHARD (US) | 1993-05-27 | — | — | WO | disclosed |
| WO-1991017751-A1 | ORALLY ADMINISTRABLE GALLIUM COMPOSITIONS AND METHODS OF TREATMENT THEREWITH | FUJISAWA, INC. (US) | 1991-11-28 | — | — | WO | disclosed |